Newsroom
Bausch & Lomb Announces Results of Tender Offer
ROCHESTER, N.Y. - Bausch & Lomb (NYSE: BOL) today announced the final results of its previously announced offer to purchase certain debt securities, which expired on June 2, 2006. Approximately $116 million aggregate principal amount of the Company's senior notes have been tendered for purchase at par under the tender offer:
|
CUSIP No. |
Outstanding Principal Amount |
Title of Security |
Amount Tendered |
|
071707AH6 |
$150,000,000 |
6.95% Notes due 2007 |
$16,805,000 |
|
071707AL7 |
$50,000,000 |
5.9% Notes due 2008 |
- |
|
071707AG8 |
$183,873,000 |
7.125% Debentures due 2028 |
$99,539,000 |
Bausch & Lomb Senior Vice President and Chief Financial Officer Stephen C. McCluski said, "Following this tender offer, our interest expense will be reduced and our liquidity will remain strong. Demonstrating that, we will retire the tendered notes using available cash on hand, rather than drawing down on any of our existing credit facilities."
Bausch & Lomb is the eye health company, dedicated to perfecting vision and enhancing life for consumers around the world. Its core businesses include soft and rigid gas permeable contact lenses and lens care products, and ophthalmic surgical and pharmaceutical products. The Bausch & Lomb name is one of the best known and most respected healthcare brands in the world. Founded in 1853, the Company is headquartered in Rochester, New York. Bausch & Lomb's 2004 revenues were $2.2 billion; it employs approximately 12,400 people worldwide and its products are available in more than 100 countries. More information about the Company can be found on the Bausch & Lomb Web site at www.bausch.com . Copyright Bausch & Lomb Incorporated.
® / TM denote trademarks of Bausch & Lomb Incorporated.
